Matches 1 - 50 out of 220 1 2 3 4 5 >


Match Document Document Title
US20130273136 SUSTAINED DRUG DELIVERY SYSTEM  
A drug delivery system for delivering a drug at a sustained constant rate for a long period, which can be transplanted into an affected part safely and in a simple manner and can deliver a drug to...
US20120177717 SUSTAINED DRUG DELIVERY SYSTEM  
Disclosed is a drug delivery system for delivering a drug at a sustained constant rate for a long period, which can be transplanted into an affected part safely and in a simple manner and can...
US20130156841 METHOD OF REDUCING INCIDENCE OF INTRAOCULAR PRESSURE ASSOCIATED WITH INTRAOCULAR USE OF CORTICOSTEROIDS  
A method of treating an ocular disease in a subject using a corticosteroid with reduced incidence of intraocular pressure lowering surgery comprises injecting an intravitreal insert capable of...
US20110150967 METHOD OF REDUCING INCIDENCE OF INTRAOCULAR PRESSURE ASSOCIATED WITH INTRAOCULAR USE OF CORTICOSTEROIDS  
A method of treating an ocular disease in a subject using a corticosteroid with reduced incidence of intraocular pressure lowering surgery comprises injecting an intravitreal insert capable of...
US20120207809 Method and system for effecting changes in pigmented tissue  
Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are...
US20140161863 DRUG DELIVERY METHODS, STRUCTURES, AND COMPOSITIONS FOR NASOLACRIMAL SYSTEM  
A drug insert is configured for use with an implant. The implant is configured for insertion into a lacrimal canaliculus. The drug insert includes a drug core comprising a therapeutic agent and a...
US20130101658 DRUG DELIVERY METHODS, STRUCTURES, AND COMPOSITIONS FOR NASOLACRIMAL SYSTEM  
A drug insert is configured for use with an implant. The implant is configured for insertion into a lacrimal canaliculus. The drug insert includes a drug core comprising a therapeutic agent and a...
US20120114734 NANOSTRUCTURE SURFACE COATED MEDICAL IMPLANTS AND METHODS OF USING THE SAME  
Compositions including a surface or film comprising nanofibers, nanotubes or microwells comprising a bioactive agent for elution to the surrounding tissue upon placement of the composition in a...
US20120076848 METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE  
Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are...
US20110238075 DRUG DELIVERY DEVICES AND METHODS  
This disclosure relates generally to methods and devices for use in treating eye conditions with implantable drug delivery devices. One method includes introducing an implant into the...
US20130236525 Sustained release intraocular implants and related methods  
Biocompatible intraocular implants include a steroid and a polymer associated with each other to facilitate release of the steroid into an eye for a period of time greater than about two months....
US20130017244 Sustained release intraocular implants and related methods  
Biocompatible intraocular implants include a steroid and a polymer associated with each other to facilitate release of the steroid into an eye for a period of time greater than about two months....
US20110236457 Micronized Device for the Delivery of Biologically Active Molecules and Methods of Use Thereof  
The invention provides micronized encapsulated cell therapy devices that are capable of delivering a biologically active molecule to the eye. Also provided are methods of using the same to deliver...
US20150104491 SUSTAINED-RELEASE RESERVOIR IMPLANTS FOR INTRACAMERAL DRUG DELIVERY  
The present invention provides a sustained release implant for intraocular use to treat elevated intraocular pressure, which implant is configured for intracameral or anterior vitreal...
US20130017243 SUSTAINED-RELEASE RESERVOIR IMPLANTS FOR INTRACAMERAL DRUG DELIVERY  
The present invention provides a sustained release implant for intraocular use to treat elevated intraocular pressure, which implant is configured for intracameral or anterior vitreal...
US20140294914 INTRAOCULAR ENCAPSULATION OF OXYGENIC BACTERIA  
Exemplary embodiments comprise an implantable ophthalmic device comprising at least one shell encapsulating oxygenic bacteria and growth medium and designed to increase the oxygen partial pressure...
US20110159073 METHODS AND DEVICES FOR THE TREATMENT OF OCULAR CONDITIONS  
Featured is a method for instilling one or more bioactive agents into ocular tissue within an eye of a patient for the treatment of an ocular condition, the method comprising concurrently using at...
US20110111007 INHIBITION OF RETINAL CELL DEGENERATION OR NEOVASCULARIZATION BY CERIUM OXIDE NANOPARTICLES  
The presently claimed and disclosed inventive concept(s) provides methods for reducing, reversing or inhibiting retinal cell degeneration, or neovascularization in tissues of a mammalian subject...
US20080279913 Use of salicylaldehyde isonicotinoyl hydrazone (SIH) for protection against retinal disease  
This invention relates to methods for treating age-related macular degeneration, blindness or glaucoma using an iron-chelator SIH.
US20100040669 Non-Invasive Ocular Delivery of Rapamycin  
Methods and systems for preventing or treating various ocular conditions are disclosed and described. In one aspect, for example, a method for noninvasively delivering a water insoluble macrolide...
US20060134169 Polymerizable surfactants and their use as device forming comonomers  
This invention describes the use of polymerizable surfactants as comonomers in forming ophthalmic devices such as contact lenses, intraocular lenses, corneal implants, etc.
US20050244466 Photodynamic therapy in conjunction with intraocular implants  
A method for treating an ocular condition is provided. The method includes the steps of placing into an eye, a bioerodible implant comprising an anti-inflammatory component and a bioerodible...
US20060013858 Fludrocortisone treatment for hearing loss  
Methods and compositions for treating or stabilizing hearing loss due to cochlear disorders by administration of compositions that include fludrocortisone or a mimetic or analog thereof are disclosed.
US20110076320 STEM CELL CULTIVATION DEVICES AND METHODS  
The present invention relates to a device and methods for culturing stem cells, and in particular, for culturing ocular stem cells and the use of stem cells cultured using the devices and methods...
US20150132358 PUNCTAL PLUG WITH ACTIVE AGENT  
A method and apparatus for administering an active agent such as a medicine to a subject, uses an ocular implant such as a punctal plug, to which the active agent has been applied. The implant is...
US20070248646 Use of azurocidin inhibitors in prevention and treatment of ocular vascular leakage  
Provided are methods for alleviating a symptom of an eye condition by administering to a mammal an amount of azurocidin inhibitor effective to alleviate the symptom of the eye condition.
US20100310630 COATED SURFACE FOR CELL CULTURE  
The invention makes available a keratin coating of a support substrate and a method for the production thereof. This keratin coating is suitable particularly for the in vitro or in vivo culturing...
US20070014833 Treatment of eye disorders with sirtuin modulators  
Sirtuin modulators, particularly sirtuin activators, are useful in treating vision impairment. In general, the sirtuin modulators inhibit the progression of vision impairment resulting from...
US20110184358 PULSATILE PERI-CORNEAL DRUG DELIVERY DEVICE  
The present invention is directed to a pulsatile ophthalmic peri-corneal drug delivery device. The device includes an annular body and a mechanism for releasing multiple separate and distinct...
US20070031471 Uses of Amniotic Membranes as Biocompatible Devices  
Amniotic membranes provided as emulsions to provide desirable features. The emulsion, containing micron or submicron sized particles of amniotic membrane, is formulated to increase absorption and...
US20140199366 SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND METHODS FOR TREATING OCULAR NEUROPATHIES  
Biocompatible intraocular implants include a beta adrenergic receptor antagonist and a polymer associated with the beta adrenergic receptor antagonist to facilitate release of the beta adrenergic...
US20110091520 Sustained Release Intraocular Implants and Methods for Treating Ocular Neuropathies  
Biocompatible intraocular implants include a beta adrenergic receptor antagonist and a polymer associated with the beta adrenergic receptor antagonist to facilitate release of the beta adrenergic...
US20100278897 INTRAOCULAR BIOACTIVE AGENT DELIVERY SYSTEM WITH MOLECULAR PARTITIONING SYSTEM  
The present disclosure generally provides intraocular implants including at least one therapeutic bioactive agent and a molecular partitioning system. The molecular partitioning system comprises...
US20050214345 Artificial biocompatible material as a support for cells in a retinal implant  
A retinal implant is provided that uses an artificial biocompatible material as a support material on which retinal pigment epithelial cells, iris pigment epithelial cells, and/or stem cells can...
US20070280994 Ocular Tissue Separation Areas With Barrier Regions For Inlays Or Other Refractive Procedures  
Ocular tissue separation areas having a barrier region are described herein. In one embodiment, the tissue separation area can have an implant placement site configured to accept an ocular...
US20090196905 STABILIZATION OF MITOCHONDRIAL MEMBRANES IN OCULAR DISEASES AND CONDITIONS  
Methods of treating ocular diseases and conditions using biodegradable ocular implants containing cyclosporine to inhibit mitochondrial permeability transition pore formation are disclosed.
US20050281862 Non-aspirating transitional viscoelastics for use in surgery  
Non-aspirating viscoelastics, compositions, and methods of use are disclosed. The non-aspirating, transitional viscoelastics possess sufficient viscosity to be useful in ophthalmic viscosurgery,...
US20100233241 OPHTHALMIC DRUG DELIVERY SYSTEM AND APPLICATIONS  
An ocular device for insertion into an eye is provided and includes a body having an anterior surface and a posterior surface for placement on one of superior sclera and inferior sclera of the...
US20100129424 Contact drug delivery system  
A drug delivery system is disclosed. The drug delivery system includes a recognitive polymeric hydrogel through which a drug is delivered by contacting biological tissue. The recognitive polymeric...
US20060029684 Synergistic treatment of DNA viral infections  
The synergistic combination of a loop diuretic and lithium is useful in the treatment of DNA viral infections.
US20080124376 OCULAR DEVICES AND METHODS OF MAKING AND USING THEREOF  
Described herein are stable ocular devices that immobilize and deliver bioactive agents to the eye over sustained periods of time. Also described herein are methods of making and using the ocular...
US20060204548 Microimplants for ocular administration  
Implants and microimplants are provided comprising homogeneous mixtures of active ingredient and bioerodible polymer, including microimplants having diameters of 0.019 inches or less and which can...
US20110129516 OCULAR DRUG DELIVERY DEVICES  
A method of forming an ocular delivery device includes exposing a solid, shaped cellulose polymer to a solution including an active pharmaceutical ingredient (API) and a solvent capable of...
US20050118231 Solid dosage form for the ocular administration of an active principle, a soluble, solid ophthalmic insert and the production method thereof  
A solid dosage form for the ocular administration of an active principle includes at least one biocompatible, water-soluble excipient for ophthalmic use. The form is obtained using a method which...
US20060233859 Methods for treating retinopathy with extended therapeutic effect  
Methods for treating and preventing retinopathic conditions by administering a glucocorticoid to the vitreous chamber of a patient at risk of, or suffering from, the retinopathy.
US20150064230 SUSTAINED RELEASE DELIVERY OF ONE OR MORE AGENTS  
The lacrimal implant delivery systems and methods described herein provide for controlled release of a therapeutic agent for the treatment of disease, including the treatment of glaucoma, ocular...
US20110182968 Interpenetrating polymer network hydrogel corneal prosthesis  
The present invention provides materials that have high glucose and oxygen permeability, strength, water content, and resistance to protein adsorption. The materials include an interpenetrating...
US20070224246 Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods  
Biocompatible intraocular implants, such as microparticles, include a prostamide component and a biodegradable polymer that is effective in facilitating release of the prostamide component into an...
US20120087970 Apparatus and Method for Removing Epithelium from the Cornea  
An apparatus and a method for removing epithelium from the cornea include a fluid agent for facilitating de-epithelialization of the cornea. A disc includes a biocompatible material operable for...
US20080003260 Use of 5-fluorourcil, delivered by iontophoresis as an inhibitor of cell proliferation in the eye, bulbar and palpebral conjunctiva, eyelid, peri-orbital soft tissues and skin  
A method for treating neoplastic, angiogenic, fibroblastic, and/or immunosuppressive ocular irregularities of a living subject, comprising the steps of: providing a living subject, wherein the...

Matches 1 - 50 out of 220 1 2 3 4 5 >